Last reviewed · How we verify
NCT04727593: MINDGAP
The Modulatory Role of Internet MBCT on Extracellular Vesicles and Distress in Cancer Patients - Study Protocol
NA trial testing Mindfulness Based Cognitive Therapy (MBCT) in Cancer in 111 participants. Status unknown.
1 March 2024
Quick facts
| Lead sponsor | Instituto Portugues de Oncologia, Francisco Gentil, Porto |
|---|---|
| Phase | NA |
| Status | Status unknown |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | none |
| Primary purpose | supportive care |
| Enrollment | 111 |
| Start date | 3 September 2021 |
| Primary completion | 1 March 2024 |
| Estimated completion | 31 March 2024 |
| Sites | 1 location across Portugal |
Drugs / interventions tested
- Mindfulness Based Cognitive Therapy (MBCT)
- Treatment as Usual
Conditions studied
- Cancer — all drugs for Cancer →
Sponsor
Instituto Portugues de Oncologia, Francisco Gentil, Porto
Who can join
Adults 18 to 65, any sex, with Cancer. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Mindfulness-based interventions (MBIs), such as mindfulness-based stress reduction (MBSR), mindfulness-based cognitive therapy (MBCT), mindfulness-based cancer recovery (MBCR), have been showing promising results in different health-related and psychosocial outcomes in the context of cancer. More recently, the possibility of delivering MBIs using technological tools and resources, such as internet and applications, has been receiving much attention, also accompanied by promising findings. However, few randomized controlled studies have been conducted and published to date. Moreover, few studies have addressed the long-term stability and trajectory of gains across time. Also, even though prior evidence had suggested that face-to-face MBIs might modulate several biological markers (e.g., pro-inflammatory gene expression and inflammatory signaling; telomere length), as far as we know, no previous study addressed the impact of online MBIs on biological indices, especially on extracellular vesicles (EVs). As primary objective, this study aims to investigate the effects of an internet-based MBCT intervention (vs. Treatment as Usual - TAU) on EVs (objective measure), as well as on psychological distress (subjective measure), considering a sample of distressed people with history of breast, prostate, and colorectal cancer. As secondary objective, this study aims to investigate the effects of this same intervention on psychosocial outcomes, including quality of life, fear of cancer recurrence, emotion suppression, mindfulness, sleep quality, posttraumatic growth, health-related behaviours (physical activity; smoking habits), and perceived social support. The biological secondary outcomes studied will be: inflammatory response genes interleukins (ILs, IL-1, IL-6, IL-8, IL-10), interferon gamma (IFN-γ), tumour necrosis factor (TNF), and c-reactive protein (CRP); telomerase activity; antigens related to cancer (cancer antigen - CA 15-3; prostate-specific antigen - PSA; carcinoembryonic antigen - CEA); other health-related markers (adrenocorticotropic hormone - ACTH; erythrocytes number; hemoglobin glycosylated).
Publications & conference data
4 peer-reviewed publications reference this trial (live from Europe PMC):
-
Extracellular Vesicles in cancer: from isolation and characterization to metastasis, drug resistance, and clinical applications.
Jurj A, Paul D, Calin GA. · · 2025 · cited 4× · PMID 40629268 · DOI 10.1186/s12885-025-14375-7 -
The modulatory role of internet-supported mindfulness-based cognitive therapy on extracellular vesicles and psychological distress in people who have had cancer: a protocol for a two-armed randomized controlled study.
Pereira DR, Silva ER, Carvalho-Maia C, Monteiro-Reis S, et al · · 2022 · cited 3× · PMID 35123569 · DOI 10.1186/s13063-022-06045-x -
Potential Effect of Extracellular Vesicles in Clinical Settings of Lymphoma.
Mamgain G, Yadav SRM. · · 2025 · PMID 39835236 · DOI 10.1007/s12291-023-01156-x -
The Modulatory Role of Internet-Supported Mindfulness-Based Cognitive Therapy on Extracellular Vesicles and Psychological Distress in People Who Have Had Cancer: A Protocol for A Two-Armed Randomized Controlled Study
Pereira D, Silva ER, Carvalho-Maia C, Monteiro-Reis S, et al · · 2021 · DOI 10.21203/rs.3.rs-968587/v1
Verify or expand the search:
- PubMed search for NCT04727593
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Mindfulness Based Cognitive Therapy (MBCT)
Trials testing the same drug.
- NCT03361514 — Discontinuation of Antidepressant Medication in Primary Care. · NA · completed
- NCT02794376 — Mindfulness for Irritable Bowel Syndrome · NA · completed
- NCT02472483 — Effectiveness of TCC Followed by MBCT and Predictive Factors (Genetic, Clinical and Cognitive) Response · NA · terminated
Other recruiting trials for Cancer
Currently open trials in the same condition.
- NCT07390045 — Exercise and Cognitive Rehabilitation Interventions for Older Cancer Survivors · NA · recruiting
- NCT07528547 — Hypersight and Ethos In Pediatric Radiotherapy · NA · recruiting
- NCT07481890 — Feasibility and Efficacy of the EMDR Toolbox Method in Cancer Patients. · NA · recruiting
- NCT07402057 — Implementation and Evaluation of a Program Aimed at Facilitating Palliative Care Conversations · NA · recruiting
- NCT07305740 — On-Trac: An Online Intervention for Cancer Survivors Managing Anxiety · NA · recruiting
Other Instituto Portugues de Oncologia, Francisco Gentil, Porto trials
Trials by the same sponsor.
- NCT04768218 — BLI for the Diagnosis of Precancerous Conditions · completed
- NCT04613570 — SUrveillance of PREMalignant Stomach - Individualized Endoscopic Follow-up · NA · recruiting
- NCT03830658 — Effectiveness of a Structured Intervention on the Development of Self-Care Behaviors With AVF in HD Patients · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04727593 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Instituto Portugues de Oncologia, Francisco Gentil, Porto
- Last refreshed: 5 September 2023
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04727593.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing